Abbott India Q1 net up 71% to Rs 51 cr

Tags: Companies
Drug firm Abbott India today posted 71.42 per cent rise in its net profit to Rs 50.93 crore for the first quarter ended June 30.

The company had posted a net profit of Rs 29.71 crore for the same period of previous fiscal.

Net sales of the company rose to Rs 516.91 crore for the first quarter, as compared to Rs 429.68 crore during the same period of previous fiscal, Abbott India Ltd said in a filing to the BSE.

In 2010, Abbott acquired both the pharmaceutical business of Solvay, which had a presence in India, and Piramal Healthcare Solutions, which was part of Piramal Group.

These transactions made it one of the largest health care companies in the country. It now employs about 14,000 people in India, making it the firm's largest employee base outside the US.

Shares of Abbott India were trading at Rs 2,330 apiece on the BSE, up 7.08 per cent from its previous close.

EDITORIAL OF THE DAY

  • Naidu must improve urban infrastructure to avoid the mess in which he landed

    While some tweets may have triggered turbulence in Air (India), the magnitude of the problem demands an immediate action plan to ease the lives of Ind

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Simon J Evenett

When machines start writing well

For centuries children through to university st­udents have practiced improving ...

Zehra Naqvi

How does a bird learn to sing?

There’s nothing like bir­dsong to give you a taste of ...

Dharmendra Khandal

The unfortunate death of a tigress & its repercussions

In nature it is not easy to gather investigative evidences, ...